688566 Jiangsu Jibeier Pharmaceutical Co., Ltd.
- 28.29
- +1.00+3.66%
Jiangsu Jibeier Pharmaceutical Co., Ltd. News
Guojin Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on Jiangsu Gibel Pharmaceutical Co., Ltd.
Guojin Securities Co., Ltd. summary report on the initial public offering of shares of Jiangsu Gibel Pharmaceutical Co., Ltd. and continued supervision and sponsorship of its listing on the Science and Technology Innovation Board
Gibel's announcement on holding a briefing on the results and cash dividends for the first quarter of 2023 and 2024
Jiangsu Gibel Pharmaceutical Co., Ltd. Investor Relations Activity Record Form April 26, 2024
Accountants' Response to the Issuer's Implementation Letter on the Issuer's Simple Procedure to Issue Shares to Specific Targets
Announcement of Resolutions of the 6th Meeting of the Fourth Board of Supervisors of Gibbel
Gibel 2023 Profit Distribution Plan Announcement
Independent opinions of independent directors of Jiangsu Jebel Pharmaceutical Co., Ltd. on matters related to the sixth meeting of the fourth board of directors
Special report on the storage and actual use of funds raised by Gibel in 2023
Xinyong Zhonghe Certified Public Accountants (Special General Partnership) Audit Report on the Annual Storage and Use of Funds Raised by Jiangsu Gibel Pharmaceutical Co., Ltd. in 2023
Gibbel 2023 Annual Report Summary
Gibbel 2023 Annual Report
Gibbel 2023 Audit Report
Legal Opinion of Beijing King & Wood Mallesons Law Firm on the Issuance of Shares by Jiangsu Gibel Pharmaceutical Co., Ltd. to Specific Targets
Guojin Securities Co., Ltd.'s listing sponsorship for Jiangsu Gibel Pharmaceutical Co., Ltd. to issue shares to specific targets
Responses from issuers and sponsors to the letter of implementation of the opinions of the Review Center on the Company's simplified procedure for issuing shares to specific targets
Guojin Securities Co., Ltd. inspection opinions on the storage and use of funds raised by Jiangsu Gibel Pharmaceutical Co., Ltd. in 2023
Gibel's announcement on requesting the shareholders' meeting to extend the authorization for the board of directors to issue shares to specific targets through simple procedures
Gibel 2024 First Quarter Report
Special Audit Report of Xinyong Zhonghe Certified Public Accountants (Special General Partnership) on the summary of non-operating capital occupation and other related capital transactions of Jiangsu Gibel Pharmaceutical Co., Ltd.
Analysis
Price Target
No Data
